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can be found in almost any type of cell ( 1 ). Currently, the 
role of lipid droplets in the pathophysiology of obesity-
dependent metabolic diseases involving insulin resistance 
is studied intensively ( 2 ). Lipid droplets are also present in 
various types of infl ammatory cells ( 3–6 ), where they are 
usually called lipid bodies (LB) and participate in cell sig-
naling and in the generation of biologically active lipid 
mediators evoked by infl ammatory and infectious condi-
tions ( 7–11 ). 
 Lipid bodies consist of a neutral lipid core that is sur-
rounded by a monolayer of amphipathic lipids (phospho-
lipids and unesterifi ed cholesterol) and by proteins 
involved in the formation and traffi cking of the LBs and in 
the turnover of their lipids. Depending on the type and 
metabolic state of a cell, the protein and lipid composi-
tions of the LBs may vary considerably, refl ecting active 
metabolism of their lipid components ( 12 ). The main pro-
teins known to regulate the metabolism of the LB lipids 
are the members of the PAT protein family, mostly studied 
in adipocytes. This family includes fi ve perilipins: perilipin 
1 (PLIN1; formerly perilipin), perilipin 2 (PLIN2; for-
merly adipose differentiation-related protein), perilipin 3 
(PLIN3; formerly tail-interacting protein of 47 kDa), per-
ilipin 4 (PLIN4; formerly S3-12), and perilipin 5 (PLIN5; 
formerly lipid storage droplet protein 5) ( 13 ). PLIN1 reg-
ulates the lipolytic activity of adipose triglyceride lipase 
(ATGL) during triacylglycerol (TG) mobilization via inter-
acting with its coactivating factor, the comparative gene 
identifi cation 58 (CGI-58) ( 14 ), whereas overexpression 
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blood donors (Finnish Red Cross Blood Transfusion Service, 
Helsinki, Finland). The buffy coats were suspended in PBS, 
layered over Ficoll-Paque (1.77 g/l) (GE Healthcare), and the 
interface containing mononuclear cells was harvested after cen-
trifugation. CD34 + progenitor cells were enriched by positive im-
munomagnetic selection using MACS affi nity columns (Milteny, 
Biotec). The isolated CD34 + cells were cultured at 37°C under 
serum-free conditions in Iscove’s Modifi ed Dulbecco’s Medium 
(IMDM) supplemented with BIT 9500 serum substitute (Stem-
Cell Technologies), L-glutamine (2 mM), 2-mercaptoethanol 
(0.1 mM), penicillin (100 U/ml) and streptomycin (100 µg/ml), 
human recombinant SCF (100 ng/ml), and different human re-
combinant cytokines (all from PeproTech, Rocky Hill, NJ). The 
human MC line LAD2, originally established from a MC sarcoma 
( 25 ), was cultured at 37°C under serum-free conditions in IMDM 
containing BIT 9500 serum substitute, L-glutamine (2 mM), 
2-mercaptoethanol (0.1 mM), penicillin (100 U/ml), streptomy-
cin (100 µg/ml), and human recombinant SCF (100 ng/ml). 
 Oil Red O staining of cells 
 Mast cells were sedimented ( Cytospin , Shandon Instruments) 
onto glass slides (15 × 10 3 cells/slide) and fi xed with 10% neutral 
buffered formalin solution (Sigma). The cells were then stained 
with Oil Red O for 30 min and counterstained with Mayer’s he-
matoxylin. Coverslips were mounted with aqueous medium to 
retain Oil Red O staining (Aquamount, DAKO). Images were 
captured with a Nikon Eclipse E600 microscope (original magni-
fi cation, 40×). 
 Flow cytometry 
 Lipid bodies in cultured MCs were quantifi ed by fl ow cytome-
try. For this purpose, the MCs were fi rst probed with monoclonal 
anti-human c-kit antibody [allophycocyanin (APC)-conjugated 
mouse anti-human CD117, 4 µg/ml, BD Pharmingen] for 20 min, 
after which the cells were incubated with the fl uorescent dye BO-
DIPY 493/503 (10 µg/ml, Molecular Probes) for 10 min to stain 
intracellular LBs. Subsequently, the cells were washed, resus-
pended in PBS, and analyzed (1 × 10 4 cells/measurement) using 
a LSR II fl ow cytometer (BD Pharmingen). To quantify LBs in 
MCs after exocytosis of their cytoplasmic secretory granules (de-
granulation), the MCs were fi rst passively sensitized in the pres-
ence of human IgE (1 µg/ml, DiaTec), and then triggered to 
degranulate by incubating them in the presence of polyclonal 
rabbit anti-human IgE (1 µg/ml, Millipore) for 1 h. Finally, the 
degranulated MCs were fi xed with 4% paraformaldehyde in PBS 
(pH 7.4) for 15 min at room temperature, washed, and resus-
pended in FACS buffer (PBS containing 0.5% BSA and 0.025% 
NaN 3 ). For staining of intracellular organelles, the cells were per-
meabilized by incubation in FACS buffer containing 1% saponin 
for 20 min at room temperature. The permeabilized cells were 
then incubated with primary antibodies (mouse anti-human MC 
tryptase, 10 µg/ml, ABD Serotec; or APC-conjugated mouse IgG1 
  Isotype Control, BD Pharmingen) for 75 min at 4°C, washed, 
and probed with secondary antibody [phycoerythrin (PE)-conju-
gated goat anti-mouse IgG, 2 µg/ml, BD Pharmingen]. Prior to 
FACS analysis, the cells were stained with BODIPY 493/503 
(10 µg/ml) for 10 min at room temperature. Unstimulated MCs 
served as controls and were analyzed exactly as described for the 
activated MCs. 
 Incubation of mast cells with fatty acids 
 Fatty acid:BSA complexes were prepared as follows. Stock solu-
tions of a fatty acid sodium salt (stearate, Sigma, S3381; oleate, 
Sigma, O7501; or arachidonate, Sigma, A8798) were combined 
with a stock solution of fatty acid-free BSA (Sigma, A6003) at a 
of PLIN2 enhances the accumulation of lipids in newly 
formed LBs by inhibiting   -oxidation ( 15 ). PLIN3 has 
been shown to enhance TG accumulation by binding and 
transporting free fatty acids from cytoplasm to LBs ( 16 ). 
PLIN4 is predominantly expressed in fat-storing adipose 
tissue, and similar to PLIN3, it is translocated from cyto-
plasmic compartments to LBs upon incubation with fatty 
acids ( 17 ). Finally, PLIN5, which is solely expressed in fatty 
acid-oxidizing tissues, has been shown to interact with 
CGI-58 or ATGL, thus leading to either an increase or de-
crease in lipolysis, respectively ( 18 ). 
 In the present work, we have studied the PAT proteins 
in the LBs of one type of infl ammatory cell, the mast cell 
(MC). Mast cells derive from progenitor cells that leave 
the bone marrow, circulate in the bloodstream, and home 
in to virtually all vascularized tissues ( 19 ). There, the pro-
genitor cells differentiate into mature MCs, with stem cell 
factor (SCF) being the major local factor responsible for 
the differentiation process ( 20 ). Comprehensive electron 
microscopic studies of MCs in various tissues have revealed 
that LBs are found particularly in human lung ( 3 ) and gut 
MCs ( 21 ), and sometimes in skin MCs ( 22 ). 
 A signifi cant observation by Dvorak et al. was that LBs in 
MCs serve as storage sites for arachidonic acid (AA), a 
fi nding that implicated these organelles in eicosanoid bio-
synthesis in MCs ( 3 ). Since then, surprisingly little knowl-
edge has been gained about the lipid composition of MC 
lipid bodies, and no information is available about which, 
if any, of the various PAT family members they contain. 
Fortunately, several protocols for the generation of hu-
man MCs have been established ( 23 ), rendering it possible 
to perform detailed studies on formation, structure, and 
function of LBs in these cells. We have recently defi ned 
culture conditions to generate mature and functional 
human MCs of the connective tissue type from peripheral 
blood-derived CD34 + progenitors in the presence of SCF 
( 24 ). In the present work, we found that differentiation of 
such CD34 + progenitor cells into mature MCs invariably 
associates with a steady increase in the number and size of 
LBs. Treatment of MCs with unsaturated fatty acids accel-
erated the formation of LBs, and exogenously added 
arachidonic acid was effi ciently incorporated into triacyl-
glycerols, the predominant lipid class in the bodies. PLIN2 
and PLIN3 were expressed in the developing and mature 
MCs, the former member being localized to the surface of 
LBs, and the latter being distributed throughout the cyto-
plasm in a punctate pattern. The demonstration of the 
genesis in cultured human MCs of arachidonate-enriched, 
PAT protein-containing LBs opens new avenues for de-
tailed mechanistic studies of the specifi c functions of LBs 
in the pathobiology of these infl ammatory cells. 
 MATERIALS AND METHODS 
 Cell culture 
 Mature human MCs were generated exactly as described previ-
ously ( 24 ). Briefl y, CD34 + progenitor cells were obtained from 
fresh buffy coats prepared from peripheral blood of healthy 
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samples were mounted in fl uorescence mounting medium 
(DAKO), and z-stacks were captured with a 63× Plan Apo NA 1.40 
lens of a LSM 5 DUO confocal laser scanning microscope 
(Zeiss). 
 Transmission electron microscopy 
 Mast cells were fi xed with 2% glutaraldehyde in 0.1 M Na-caco-
dylate buffer (pH 7.4) for 2 h at room temperature, and then 
pelleted by low-speed centrifugation, resuspended in 0.1 M Na-
cacodylate buffer, and embedded in 2% low-melting agarose 
(Sigma, A9045). Briefl y, the standard transmission electron mi-
croscopy (TEM) processing involved postfi xation with 1% os-
mium tetroxide, after which the samples were dehydrated 
through a graded series of ethanol and acetone, and gradually 
embedded in Epon. After polymerization at 60°C for 16 h, thin 
sections were cut and mounted on copper grids and stained with 
uranyl acetate and lead citrate. The stained sections were viewed 
at 80 kV with a Tecnai 12 transmission electron microscope (EM 
Unit, Institute of Biotechnology, University of Helsinki) using a 
1k × 1k Gatan Multiscan 794 CCD camera. Montages (3k × 3k) 
were collected using the Gatan montage software. 
 Isolation of lipid bodies 
 Lipid bodies were isolated as described by Prattes et al. ( 26 ). 
Briefl y, MCs were collected by centrifugation (300  g ), washed 
with PBS, and gently resuspended with H 2 O for cell lysis. The 
lysates were layered onto 250 mM sucrose, 50 mM Tris, pH 7.4, 
25 mM KCl, and 5 mM MgCl 2 , and centrifuged at 70,000  g at 4°C for 
1 h. The LBs fl oated to the top fraction, which was collected and 
used for further analyses. 
 Thin-layer chromatography 
 Lipids were extracted from isolated LBs according to the 
method of Bligh and Dyer ( 27 ). Solvents were evaporated under 
nitrogen, and the lipids were dissolved in chloroform:methanol 
(2:1; v/v). Various lipid classes were separated by thin-layer chro-
matography (TLC) on HPTLC Silica gel 60 (Merck, Germany). 
Hexane:diethylether:acetic acid:H 2 O (26:6:0.4:0.1; v/v) and 
chloroform:methanol:acetic acid:H 2 O (10:3:1.6:0.7; v/v) were 
used as solvents for neutral lipids and phospholipids, respec-
tively. The separated lipids were visualized by exposing the Silica 
gels to 3% CuSO 4 and 8% H 3 PO 4 and subsequent heating at 
160°C. Appropriate lipid standards were purchased from Sigma. 
 Mass spectrometry 
 Mast cells were incubated with arachidonate:BSA complexes 
(molar ratio 6:1; fi nal arachidonate concentration, 400 µM), and 
the LBs were isolated as described above. Subsequently, the lipids 
of the LBs were extracted according to Folch et al. ( 28 ). After 
evaporation under constant nitrogen fl ow, the extracted lipids 
were dissolved in chloroform:methanol (1:2, v/v) containing 4% 
aqueous NH 3 (25% solution added just prior to analysis) for di-
rect infusion experiments (fl ow rate 7 µl/min) using a Quattro 
Micro triple-quadrupole electrospray ionization mass spectrom-
eter (Micromass, Manchester, UK). The instrument was used to 
detect positive ions either in the single-stage or in tandem MS 
mode. A fi ngerprinting method detecting neutral losses of AA 
and of other fatty acids from TG (M+NH 4 ) 
+ ions was applied 
( 29 ). Nitrogen was used as the nebulizer (500 l/h) at 130°C, and 
argon was used as the cone gas (40 l/h). The source temperature 
was set to 80°C. The cone, extractor, and RF lens potentials were 
set at 50 V, 2 V, and 0.3 V, respectively. A voltage of 3.8 kV was set 
for the capillary. The spectra were scanned from  m/z 300 to  m/z 
1,100 with a frequency of 1 scan/4 s. The data were analyzed 
using the MassLynx 4.0 software (Waters). 
molar ratio of 6:1 (fatty acid:BSA) under nitrogen at 37°C for 
15 min. All stock solutions were prepared in LDL buffer (150 mM 
NaCl, 0.24 mM EDTA, pH 7.4). Mast cells were incubated sepa-
rately with the various fatty acid:BSA complexes (fi nal fatty acid 
concentration, 400 µM) at 37°C for 18 h. In some experiments, 
the cells were incubated with fatty acid:BSA complexes in the 
presence of the long-chain acyl-CoA synthetase inhibitor Triascin 
C (5 µM, Enzo) or its vehicle (0.1% DMSO). After the incuba-
tions, the cells were washed twice with PBS before further 
analysis. 
 RT-PCR 
 Total RNA was isolated from cultured human MCs and LAD2 
cells (RNeasy kit, QIAGEN), and cDNA was generated by RT-
PCR (M-MLV reverse transcriptase, Promega). Human tissue mix 
cDNA (Clontech) was used as a positive control. For RT-PCR, 
specifi c oligonucleotide primers were designed for  plin1 (5 ′ -CTT 
TAA CCA AAC TTG TGG CC-3 ′ and 5 ′ -TAC TCA GAA AGT GAC 
ACT AG-3 ′ ),  plin2 (5 ′ -AGT GGA AAA GGA GCA TTG GA-3 ′ and 
5 ′ -GTC TCC TGG CTG CTC TTG TC-3 ′ ),  plin3 (5 ′ -GCT ACT 
TCG TAC GTC TGG GGC-3 ′ and 5 ′ -TTT CTC AGT GAT TCC 
AGG GG-3 ′ ),  plin4 (5 ′ -CCA AAG ACC TGG TGT GTT CC-3 ′ and 
5 ′ -AGC ACA GCC TTG GAG GTT T-3 ′ ), and  plin5 (5 ′ -GTG GCC 
AGC AGT GTC ACG GG-3 ′ and 5 ′ -GGA GCC GAG GCG CAC 
AAA GT-3 ′ ). Beta-actin primers (5 ′ -AGA GCC TCG CCT TTG 
CCG AT-3 ′ and 5 ′ -CAC CAT CAC GCC CTG GTG C-3 ′ ) were used 
as internal positive controls. All PCR products were T/A-cloned 
into pCR2.1-TOPO vector (Invitrogen) and confi rmed by DNA 
sequencing using standard sequencing primers M13F and 
M13R. 
 Immunoblotting 
 For the preparation of total cell lysates, the MCs derived from 
CD34 + progenitor cells and the LAD2 MCs were washed twice 
with PBS, lysed in RIPA buffer (50 mM Tris-HCl, 150 mM NaCl, 
2 mM EDTA, 1.1% NP40, 0.1% SDS, pH 8.0) containing com-
plete protease inhibitor cocktail (Roche), and incubated on ice 
for 1 h. The proteins in the lysate were separated by SDS-PAGE 
under reducing conditions, and then transferred onto a nitrocel-
lulose membrane (Hybond-C Extra; Amersham Biosciences). 
Nonspecifi c binding sites were blocked by incubating the mem-
brane with 5% nonfat dry milk in 1× TBS-T buffer (150 mM NaCl, 
10 mM Tris, 0.1% Tween 20, pH 8) for 1 h at room temperature. 
Immunodetection was performed using guinea pig anti-human 
adipophilin (antiserum 1:1000, GP41, Progen Biotechnik) or 
guinea pig anti-human TIP47 (antiserum 1:5000, GP30, Progen 
Biotechnik) followed by incubation with HRP-labeled rabbit anti-
guinea pig IgG (1:10 000, Invitrogen). The signals were detected 
using an enhanced chemiluminescence method (Pierce). 
 Confocal immunofl uorescence microscopy 
 Cytospin preparations of MC suspensions were fi xed with 4% 
paraformaldehyde and 0.025% glutaraldehyde for 20 min. Non-
specifi c binding sites were blocked with 3% goat serum contain-
ing 0.1% saponin and 0.2 M glycine in PBS (pH 7.4). The mast 
cells were then incubated with primary antibodies (guinea pig 
anti-human TIP47, 1:500, GP30, Progen; or mouse anti-human 
adipophilin, 16 ng/ml, AP125, Progen) in 3% goat serum con-
taining 0.1% saponin in PBS (pH 7.4) for 2 h at room tempera-
ture. After incubation, the cells were washed and probed with 
secondary antibodies (Alexa Fluor-594 goat-anti guinea pig IgG 
or Alexa Fluor-594 goat anti-mouse IgG, 4 ng/ml each; Molecu-
lar Probes) for 1 h at room temperature. Lipid bodies were visual-
ized using BODIPY 493/503 (10 µg/ml), and nuclei were 
counterstained with DAPI (4’,6-diamidino-2-phenylindole). The 
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was heterogeneous in terms of the number and size of the 
cytoplasmic LBs at any given time point of culture. Thus, 
some cells contained many large LBs, whereas other cells 
contained a variable number of small bodies or were even 
totally devoid of them. However, on average, a steady time-
dependent increase in the number and size of LBs in all 
18 cell cultures was observed, thus rendering each cell popu-
lation progressively more homogenous in terms of its neu-
tral lipid content. 
 More detailed information on the ultrastructural mor-
phology and distribution of MC lipid bodies in the cyto-
plasm was obtained by transmission electron microscopy 
(TEM). This method allowed us to identify LBs as discrete 
organelles at both early and later stages of maturation 
( Fig. 1E, F ). As previously described by Dvorak et al. ( 30 ), 
the LBs were clearly visible in the cytoplasm as electron-
dense round structures, whereas the nucleus and other 
cytoplasmic compartments were less electron dense. To 
obtain quantitative insight into the time-dependent in-
crease of number and size of MC lipid bodies, we analyzed 
the dynamics of this process by fl ow cytometry. The neu-
tral lipids in the LBs were stained with the fl uorescent dye 
BODIPY 493/503. As shown in  Fig. 2 ,  over a period of at 
least 11 weeks, fl uorescence intensities in cultured MCs 
derived from three different donors (A, B, and C) in-
creased continuously and with only small differences. 
Overall, the fi ndings demonstrate that cytoplasmic LBs are 
formed in human peripheral blood-derived CD34 + pro-
genitor cells when the cells are induced to mature into 
MCs under the well-defi ned cell culture conditions used 
here. For all following experiments, only mature MCs 
(14 weeks or older) were used. 
 To gain information on the fate of LBs upon MC activa-
tion with ensuing exocytosis of the cytoplasmic secretory 
granules, we compared resting MCs with those having 
 RESULTS 
 To generate mature and functional mast cells, human 
peripheral blood-derived CD34 + progenitor cells obtained 
from 18 different donors were cultured under serum-free 
conditions for up to 15 weeks ( 24 ). To analyze whether 
intracellular neutral lipid storage sites are formed during 
the maturation process, the MCs were stained with Oil Red 
O ( Fig. 1 ).  Six weeks after initiation of the cultures, only 
occasional small Oil Red O-positive LBs were identifi ed in 
the MCs ( Fig. 1A ). At week 9, when the cultures consisted 
of a homogenous population of cells with the phenotype 
of mature human connective tissue-type MCs [i.e., when 
all cells contained tryptase- and chymase-containing cyto-
plasmic granules (not shown)], the number of the LBs 
had dramatically increased ( Fig. 1B ). The Oil Red 
O-positive cytoplasmic LBs also gained in size, as can be 
seen when comparing the MCs at 12 weeks ( Fig. 1C ) and 
15 weeks ( Fig. 1D ) of culture. Each of the 18 cell populations 
 Fig.  1. Identifi cation of LBs in human MCs with light and with 
electron microscopy. Human peripheral blood-derived CD34 + pro-
genitor cells from 18 donors were grown under defi ned culture 
conditions, which induced their differentiation into mature MCs, 
as described in  Materials and Methods . A–D: The cells were stained 
with Oil Red O/hematoxylin at the indicated weeks in culture. 
Representative images of cells from a single donor are shown. Each 
inset shows one typical cell representative for the corresponding 
time point in culture. E, F: Mast cells from an early (6-week) and 
late (29-week) culture were analyzed by transmission electron mi-
croscopy. In each panel, one typical LB is indicated with an arrow. 
N, nucleus; wk, week. 
 Fig.  2. Quantifi cation of LBs in maturing MCs. The cumulative 
volumes of LBs in 10,000 MCs each derived from three different 
MC donors were analyzed by fl ow cytometry as a function of cul-
ture time. The results of each donor (A, B, and C) are shown as 
fl uorescence intensities. The number of weeks of culture is 
indicated. 
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reduction in BODIPY 493/503 mean fl uorescence inten-
sity was observed in the stimulated cells. In sharp contrast, 
the activated MCs showed a 40% reduction in the mean 
immunofl uorescence intensity of tryptase, thereby dem-
onstrating degranulation with an accompanying loss of 
their tryptase content. Taken together, the results confi rm 
that cytoplasmic LBs are granule-independent organ-
elles, which are not cosecreted with the granules upon MC 
activation. 
 Next, we studied the presence of LB surface proteins of 
the PAT family in the CD34 + -derived MCs and in LAD2 
MCs by RT-PCR using sequence-specifi c primers. The 
LAD2 cell line, a well-studied human MC analog, can be 
stimulated to degranulate in an IgE-dependent manner 
( 25 ). Strong expression of  plin2 and  plin4 and lower levels 
of expression of  plin1 and  plin3 were observed in CD34 + -
derived MCs ( Fig. 4 , lane 1).  Plin5 transcript was not de-
tected, even when tested under a variety of PCR conditions. 
For comparison, RT-PCR data showed that LAD2 cells also 
undergone degranulation ( Fig. 3 ).  For this purpose, MCs 
were immunologically activated by antigen-induced IgE 
cross-linking to trigger their degranulation. After 1 h of 
stimulation, no visible changes in the localization or mor-
phological appearance of intracellular LBs were observed 
( Fig. 3A, B ). Magnifi cations of representative LBs and se-
cretory granules of resting and activated MCs are shown in 
 Fig. 3C . The morphological appearance of the LBs re-
mained unaltered, whereas the electron density of the 
membrane-bound granules became reduced, refl ecting 
loss of granule components into the incubation medium 
space. To gain quantitative insight into the exocytotic pro-
cess, we analyzed the total intracellular complement of 
LBs in resting versus degranulated MCs by fl ow cytometry 
( Fig. 3D ). The extent of MC degranulation was estimated 
by determining the cellular content of the granule pro-
tease tryptase before and after stimulation, and the LB 
content was assessed by BODIPY 493/503 fl uorescence. One 
hour after the immunological stimulation, no signifi cant 
 Fig.  3. Lipid bodies in resting and degranulated MCs. A, B: Mast cells from resting and immunologically 
activated cells (at 14 weeks of culture) were analyzed by transmission electron microscopy. In both panels, 
one typical LB is indicated with an arrow. C: Magnifi cations of typical LBs and secretory granules of resting 
and activated MCs. D: Mature MCs (at 16 week of culture) were activated for 1 h via IgE cross-linking to in-
duce their degranulation (activated cells). Control cells were incubated in the absence of anti-IgE (resting 
cells). Then, all cells were fi xed, permeabilized, and incubated with anti-tryptase antibody, washed, and 
probed with phycoerythrin-conjugated goat anti-mouse IgG. Cytoplasmic LBs were stained with fl uorescent 
BODIPY 493/503, and the cells were analyzed by fl ow cytometry. The values shown are mean fl uorescence 
intensities (1 × 10 4 cells/sample) for the stimulated cells expressed as percentages of fl uorescence intensities 
of resting cells, and they represent the averages of values obtained with cells from two donors. 
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dant neutral lipid class, whereas much smaller amounts of 
cholesterol esters, nonesterifi ed fatty acids, and unesteri-
fi ed cholesterol were present in the LBs. An analysis of the 
glycerophospholipid fraction ( Fig. 7B ) revealed that the 
major phospholipid in the bodies is lyso-phosphatidylcho-
line (lyso-PC), with small amounts of phosphatidylcholine 
(PC) and sphingomyelin (SM) present. Similar results 
were obtained in isolated LBs from LAD2 cells (data not 
shown). 
 Of particular interest was to learn whether LB forma-
tion can be induced by incubation of MCs with various 
fatty acids. For this purpose, MCs were incubated for 18 h 
with stearic acid (SA; 18:0), oleic acid (OA; 18:1), or AA 
(20:4), each complexed with BSA at a molar ratio of 6:1 
(fatty acid:BSA), after which LBs were detected by Oil Red 
O staining. A clear increase in the number of LBs was ob-
served in MCs incubated with OA or AA, but not with SA 
(images not shown). This fi nding prompted us to evaluate 
the quantitative changes in LB content of fatty acid-treated 
MCs. The cells were treated with SA, OA, or AA for 18 h, 
after which the LBs were quantifi ed by fl ow cytometry 
( Fig. 8 ).  When compared with control cells, no signifi cant 
induction was observed after SA treatment, whereas the 
LB content was increased by 45% and 30% in OA- and AA-
treated MCs, respectively. We also tested the effect of Tri-
acsin C, a potent inhibitor of long-chain acyl-CoA 
synthetases 1, 3, and 4 ( 31 ) on the fatty acid-induced LB 
formation. No signifi cant inhibition of LB growth was ob-
served in MCs treated with SA. In contrast, lipid body 
growth was attenuated in OA- and AA-treated cells when 
Triacsin C was added to the incubation medium. 
 As for other infl ammatory cells, the LBs in human lung 
MCs have been reported to incorporate arachidonic acid 
into their triacylglycerols ( 10 ). Therefore, we tested 
whether the cultured MCs are capable of esterifying arachi-
donic acid into the large triacylglycerol pool of their LBs. 
For this purpose, MCs were incubated with arachidonic 
acid for 18 h, after which LBs were isolated, and their lip-
ids extracted and analyzed by tandem mass spectrometry 
( Fig. 9 ).  The positive ion mass spectrum revealed that MC 
lipid bodies contain a mixture of phospholipids and 
neutral lipids, mainly TG. The TG species were typically 
express  plin1 ,  plin2 ,  plin3 , and  plin4 , but not  plin5 ( Fig. 4 , 
lane 2). Thus, our data reveal for the fi rst time that PAT 
genes are transcribed in human MCs. The presence of 
transcripts of these four genes ( plin1 ,  plin2 ,  plin3 , and 
 plin4) , and the absence of  plin5 was confi rmed in MCs de-
rived from each human donor studied (n = 8). We next 
tested for the presence of PLIN2 and PLIN3 proteins in 
total lysates of MCs and LAD2 cells by immunoblotting 
( Fig. 5 ).  Using specifi c antibodies against PLIN2 and 
PLIN3, bands of the expected sizes (48 kDa and 47 kDa, 
respectively) were detected. In both types of MC, strong 
expression was obtained for PLIN2, whereas under our ex-
perimental conditions, PLIN3 appeared to be expressed at 
lower levels. Together, our data obtained by RT-PCR and 
immunoblotting revealed the presence in MCs of LB-asso-
ciated proteins typically found in other types of LB-con-
taining cells. 
 To obtain information about the intracellular localiza-
tion of the two PLINs, LBs in CD34 + -derived MCs were 
stained with BODIPY 493/503 fl uorescent dye, and the 
proteins were visualized by immunofl uorescence micros-
copy ( Fig. 6 ).  Confocal slices through the MCs revealed 
the localization of PLIN2 solely in the circumference of 
LBs, whereas the cytoplasm failed to show any positive 
staining for this protein ( Fig. 6A ). In contrast, PLIN3 was 
diffusely distributed in the cytoplasm of the MCs in a punc-
tate pattern and could hardly be found colocalized with 
the LBs ( Fig. 6B ). These differences were also clearly ob-
served in the respective xz- and yz-planes. 
 For compositional analysis, LBs were isolated from MCs, 
and their lipids were extracted and separated by thin-layer 
chromatography ( Fig. 7 ).  As shown in  Fig. 7A , the neutral 
lipid fraction was composed of TG, cholesteryl esters (CE), 
nonesterifi ed fatty acids (NEFA), and unesterifi ed choles-
terol (UC). Triacylglycerols represented the most abun-
 Fig.  5. PLIN2 and PLIN3 proteins in CD34 + -derived MCs and 
LAD2 MCs. Lysates of CD34 + -derived MCs (MC; 80 µg protein per 
lane) and LAD2 cells (LAD2; 70 µg protein per lane) were ana-
lyzed by Western blotting with guinea pig anti-human PLIN2 anti-
serum (lane 1) and with guinea pig anti-human PLIN3 antiserum 
(lane 2), respectively. Bound primary antibodies were visualized 
with HRP-labeled rabbit anti-guinea pig IgG. 
 Fig.  4. Expression of PAT family members in human MCs. Tran-
script levels of the PAT family members  plin1, plin2, plin3, plin4, 
 and plin5 were determined by RT-PCR using mRNA from human 
MCs at 14 wk of culture (MC, lane 1), LAD2 cells (LAD2, lane 2), 
and sets of sequence-specifi c primers. Human reference total RNA 
was used as positive control (pCtrl, lane 3), and PCR performed 
without the addition of template served as negative control (nCtrl, 
lane 4). Beta actin-specifi c primers were used to test the quality of 
cDNA templates (bottom panel). The PCR products were analyzed 
by agarose gel electrophoresis. 
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peripheral blood. As in other MC differentiation protocols 
( 23 ) and, in fact, in human tissues in vivo, the develop-
ment of MCs requires the continuous presence of stem 
cell factor. Therefore, determining the role, if any, of SCF 
on LB formation during mast cell maturation is precluded. 
In our protocol ( 24 ), the mature MCs produced are exclu-
sively of the connective tissue-type [i.e., mast cells contain-
ing both tryptase and chymase (TC-MC)]. Thus, the results 
observed in the mass range  m/z 900 to 1,050 ( Fig. 9A ). 
Scanning for the neutral loss of 321 Da specifi cally identi-
fi ed the exogenously applied arachidonic acid in the dif-
ferent triacylglycerol species ( Fig. 9B ). In fact, the most 
important AA-containing TG species contained two or 
three AA chains in the same molecule (see  Fig. 9 legend). 
These results demonstrate defi nitively that mast cells can 
incorporate AA into their TG and suggest that the triacyl-
glycerols in their lipid bodies may serve as a cytoplasmic 
storage pool for arachidonic acid. 
 DISCUSSION 
 This study focuses on the characterization of cytoplas-
mic lipid bodies in mast cells during their phenotypic mat-
uration from CD34 + progenitor cells derived from human 
 Fig.  6. Intracellular localization of PLIN2 and PLIN3 in MCs. For 
the analysis of the intracellular distribution of PLIN2 (A) and 
PLIN3 (B), MCs were probed with mouse anti-human PLIN2 or 
with guinea pig anti-human PLIN3. The primary antibodies were 
probed with Alexa Fluor-594 goat anti-mouse IgG (A) or Alexa 
Fluor-594 goat anti-guinea pig IgG (B). LBs were stained with 
BODIPY 493/503, and nuclei were counterstained with DAPI. Or-
thogonal projections of confocal z-stacks of representative LBs are 
shown (A, B). The main images of both panels show an xy-section 
of a MC at the z-positions indicated by dark blue lines in the xz-
plane (x-axis/z-axis; small top rectangular fi gure) and the yz-plane 
(y-axis/z-axis; small right rectangular fi gure). Insets (A, B) show 
magnifi ed orthogonal views of the indicated single LBs. 
 Fig.  7. Lipid composition of human MC lipid bodies. Lipid bod-
ies were isolated from human MCs at 18 wk of culture, and their 
lipids were extracted and separated by thin-layer chromatography. 
A, B: Lane 1 contains the indicated lipid standards (Std), and lane 
2 contains the lipids of the isolated LBs. A: Neutral lipids. B: Polar 
lipids. Arrowheads indicate site of sample application. 
 Fig.  8. Induction and inhibition of lipid body formation in MCs. 
Mast cells were incubated in the presence of stearic acid (18:0), 
oleic acid (18:1), or arachidonic acid (20:4), each complexed to 
BSA (molar ratio 6:1) in the absence or presence of the long chain 
acyl-CoA synthetase inhibitor Triacsin C at 37°C for 18 h. Lipid 
bodies were quantifi ed by fl ow cytometry. Fluorescence intensities 
of the treated cells are shown and expressed as percentages of the 
fl uorescence intensities of untreated control cells. Values represent 
the mean ± SD of cells (1 × 10 4 cells/sample) obtained from three 
donors (n = 3). Ctrl, control; FA, fatty acid. 
 at Terkko - N
ational Library of Health Sciences, on M
ay 16, 2016
w
w
w
.jlr.org
D
ow
nloaded from
 
Lipid bodies in human mast cells 2205
 Fig.  9. Mass spectrometric analysis of MC lipid bodies. Lipid bodies were induced in MCs by incubating the cells in the presence of arachi-
donic acid, as described in  Fig. 8 . The bodies were then isolated, and their lipids extracted and analyzed by mass spectrometry. A: Positive 
ESI-MS of total lipid extract of LBs. Triacylglycerols (small rectangular box) are detected between  m/z 880 and 1,050. B: Arachidonic acid-
containing triacylglycerols (large rectangular box) were detected by the neutral loss scan for 321 amu during ESI-MS of neutral lipids ex-
tracted from LBs. The main arachidonic-acid-containing triacylglycerol species, denoted [sum of acyl carbons]:[sum of double bonds in 
the chains] with their  m/z values and most likely acyl chain composition in parenthesis, were 58:9 ( m/z 946; 18:1-20:4-20:4), 60:12 ( m/z 968; 
20:4-20:4-20:4) and 62:12 ( m/z 996; 20:4-20:4-22:4). The intensity scales of the spectra were normalized to the largest signal in the selected 
 m/z range. amu, atomic mass unit . 
are obtained in a well-defi ned cell population represent-
ing one of the two major human mast cell types ( 32 ). Re-
cently, human cord blood-derived mast cells have been 
reported to contain LBs after in vitro differentiation and 
cultivation in the presence of 10% fetal bovine serum ( 33 ). 
Here, the mast cells were differentiated in serum-free me-
dium, which contained 1% (140   M) fatty acid-containing 
BSA. Hence, the albumin-bound fatty acids were the only 
exogenous source of lipids in the differentiation medium. 
In accordance with albumin possessing two to three high-
affi nity and up to fi ve intermediate-affi nity binding sites 
for fatty acids ( 34 ), we measured a concentration of 700 
  M fatty acids in the differentiation medium. This concen-
tration is in the range of that in the extracellular fl uids of 
the human body (i.e., in the physiological environment of 
MC differentiation in vivo). In any case, the total lipid con-
centration in the serum-free differentiation medium was 
lower than in standard cell culture media containing 10% 
serum. Based on these considerations, it is notable that the 
in vitro-differentiated mast cells generated LBs in a highly 
consistent fashion. This fact may indicate that, at least in 
part, mast cell LB formation requires cellular denovo lipid 
synthesis during maturation. The steady increase in total 
LB content in differentiating mast cells from all 18 donors 
supports the notion that LB formation is an innate prop-
erty of TC-MC. However, comparison of mast cell cultures 
from different donors at a given period of maturation re-
vealed small differences in both the average number and 
size of LBs ( Fig. 2 ). Similarly, although all mast cell cul-
tures were maintained under the same conditions, there 
were apparent minor donor-to-donor differences in the 
tendency to form cytoplasmic LBs (not shown). These 
qualitative differences may refl ect functional heterogene-
ity of the LBs, an aspect that remains to be investigated. 
Inasmuch as all donors were healthy volunteers (samples 
provided by the Finnish Red Cross Blood Transfusion Ser-
vice), such variation may also refl ect genetic heterogeneity 
of the study population. 
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conditions, be associated with the surface of LBs. In any 
case, the molecular characterization of PAT family pro-
teins provided unambiguous evidence for the LBs of 
TC-MCs being equivalent to those described in other types 
of infl ammatory cells. 
 Ultrastructural studies have revealed that the major frac-
tion of the cytoplasm of MCs is fi lled with secretory gran-
ules and that only a smaller part of the cytoplasm harbors 
LBs ( 30 ). The electron microscopic method used here was 
specifi cally aimed at the visualization of LBs and allowed 
us to distinguish them from cytoplasmic secretory gran-
ules ( Figs. 1 and 3 ). The LBs could be recognized as elec-
tron-dense organelles of various sizes and increasing 
numbers during the differentiation of MCs. Importantly, 
the total volume of LBs, as determined by fl ow cytometry, 
and their ultrastructural morphology remained unaffected 
during mast cell activation and ensuing degranulation 
( Fig. 3 ). Taken together, our observations strongly sup-
port the previous conclusion by Dvorak et al. in lung MCs 
that LBs are not cosecreted with the cytoplasmic secretory 
granules upon degranulation ( 40 ). Thus, different meth-
odologies applied to human MCs of different origin 
demonstrate that in these cells, LBs are indeed granule-
independent organelles. 
 In the LBs of the developing and mature MCs, triacyl-
glycerols were the most abundant class of lipids, whereas 
cholesteryl esters were present only in low amounts ( Fig. 
7 ). Thus, these LBs, like those of human lung MCs ( 10 ), 
appear to correspond to the lipid droplets of adipocytes 
rather than to those of macrophage foam cells. Although 
mature mast cells in various human tissues contain LBs ( 3, 
21, 22 ), the factors leading to, or required for, the genera-
tion of these organelles in the various tissue environments 
are unknown. The in vitro system for MC maturation em-
ployed here may help to identify yet unknown players in 
the processes leading to LB formation in MCs. To date, 
the stimuli described for induction of LB genesis include 
LPS, cytokines, chemokines, and fatty acids ( 41 ). Similar 
to the observations in eosinophils, monocytes, and baso-
phils ( 41 ), LB formation in MCs was found to be stimu-
lated by the unsaturated fatty acids oleic acid and 
arachidonic acid, but not with the saturated fatty acid 
stearic acid ( Fig. 8 ). Signifi cantly, the stimulatory effect 
was diminished by coincubation with Triascin C, an inhibi-
tor of long-chain acyl-CoA-synthetase (ACSL) 1, 3, and 4, 
the ACSL isoforms known to be localized to lipid droplets 
of murine adipocytes ( 31 ). Studies in progress are de-
signed to determine whether any or all of these enzymes 
activate(s) certain fatty acids required for the formation of 
MC lipid bodies. 
 Research on infl ammatory cell types has identifi ed LBs 
as active sites for the conversion of arachidonic acid, 
released from different lipids by phospholipases, into 
eicosanoids ( 7 ). However, the mechanisms by which AA-
containing TGs are formed and the AA mobilized under 
the infl uence of certain cellular stimuli remain to be de-
fi ned. Interestingly, in the context of lipid mediator for-
mation by MCs, early electron microscope studies in 
human lung MCs have revealed LBs as storage sites for 
 Regarding the implications of our observations during 
TC-MC differentiation for research on human mast cells 
in general, the following aspects of the phenotypic varia-
tion of MCs require consideration. TC-MCs are typically 
found in the skin, and they are widely distributed in most 
internal organs and tissues of the human body. Regarding 
mucosal surfaces of the body, note that in the gastrointes-
tinal tract, the mucosal and submucosal layer predomi-
nantly contain T-MCs and TC-MCs, respectively. In 
contrast, in the bronchial tree of the lung, T-MCs predom-
inate in both layers ( 32 ). Of great interest is a recent re-
port of a phenotypic switch of bronchial T-MC in severe 
asthma that results in a greater proportion of TC-MC in 
the bronchial submucosa. The increase in the number of 
TC-MC was associated with an increased concentration of 
prostaglandin D2 (PGD2) in the bronchoalveolar lavage 
fl uid. Since TC-MCs are known to produce more PGD2 
than T-MC ( 35 ), the fi ndings suggest that the excess of 
PGD2 originated in the TC-MC (i.e., the MC type studied 
in this work). In the atherosclerotic human coronary in-
tima, the relative proportion of TC-MC of all mast cells 
ranges from 0% to 100% ( 36 ). However, which, if any, of 
the mast cells populating atherosclerotic lesions contain 
LBs is not known. In analogy to the mast cells in the lung, 
eicosanoid production in the MC present in the arterial 
wall may vary depending on the severity of the disease. It 
will be of major interest to determine whether the relative 
abundance of LBs in the different types of coronary mast 
cells correlate with clinical outcomes. Moreover, as the 
generation of eicosanoids is LB dependent ( 7 ), these and 
our above-described fi ndings in diseased bronchial and 
coronary tissues support the value of in vitro-generated 
TC-MC as surrogates for the different populations of TC-
MC obtained from tissue sites with different (patho)physi-
ological microenvironments. The culture protocol for 
human TC-MC differentiation applied here should facili-
tate investigations of the roles of microenvironmental fac-
tors as they relate to the different local functions of mast 
cells, particularly the LB-dependent formation of lipid me-
diators ( 37 ). 
 Inasmuch as studies on the generation of LB-derived 
lipid mediators require a detailed characterization of the 
biology of the LBs in mast cells, we subjected MCs and 
their LBs to further analyses. Shown here for the fi rst time, 
human MCs express several PAT proteins. This family of 
proteins is associated with LB metabolism in a variety of 
cell types ( 13 ). Analysis of the TC-MCs demonstrated the 
expression of  plin1 ,  plin2 ,  plin3 , and  plin4 at the transcrip-
tional level. Among these, we selected for further analysis 
by immunofl uorescence and immunoblotting the proteins 
PLIN2 and PLIN3, as they play major roles in the stabiliza-
tion and formation of LBs in human macrophages, an-
other type of infl ammatory cell ( 38 ). In accordance with 
previous immunofl uorescence studies on human mac-
rophages ( 39 ), the images obtained by confocal micros-
copy identifi ed PLIN2 adjacent to the LB surface ( Fig. 6 ), 
whereas PLIN3 showed a diffuse distribution in the cyto-
plasm of mast cells. It remains to be ascertained by alterna-
tive methodologies whether PLIN3 can, under certain 
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arachidonic acid, suggesting that these organelles contrib-
ute to eicosanoid biosynthesis and/or metabolism ( 3 ). 
Subsequent investigations demonstrated that a remark-
able amount of arachidonic acid is associated with the 
large triacylglycerol pool of human lung MCs ( 10 ). Here, 
we show by tandem mass spectrometric analysis that the 
triacylglycerol fraction of isolated arachidonic acid-in-
duced MC lipid bodies incorporates a large portion of the 
MC’s total content of arachidonic acid. This implies that 
TC-MC lipid bodies can serve as reservoirs for arachidonic 
acid, a precursor of eicosanoid biosynthesis. 
 In conclusion, our current investigations demonstrate 
that human mast cells derived from CD34 + progenitors in 
peripheral blood, which are MCs of the connective tissue 
type (i.e., surrogates of MCs intimately involved in the 
pathogenesis of allergic asthma, rheumatoid arthritis, and 
cardiovascular diseases), may be a new tool to study regula-
tory mechanisms in LBs, with particular emphasis on 
arachidonic acid metabolism, eicosanoid biosynthesis, and 
ensuing release of proinfl ammatory lipid mediators.  
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